MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacerbations in the ULTIMATE I and II Trials Comparing Ublituximab vs Teriflunomide

0 views
April 25, 2024
Comments 1
Login to view comments. Click here to Login